An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...
The Chrisley Knows Best alum, whose parents, Todd and Julie Chrisley, spent two years in federal prison for bank and tax fraud, appears to have heeded the warning. Her website has since added ...
The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims about compounded versions of popular GLP-1 weight‑loss drugs, the ...
A narrow 10–7 vote ended GLP-1 coverage for state employees, citing high premium costs and a tight state budget.
Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.
News about intermittent fasting seems to change as frequently as the apps on your phone need upgrading. Yet another new study about the eating practice seeks to put doubts to rest after rounding up ...
A 2026 Informational Overview of the BreezeMeds Compounded GLP-1 Telehealth Weight Loss Platform, Semaglutide and Tirzepatide Medication Formats, Published Pricing Structure, 503A Compounding Pharmacy ...
Increasing your daily step count is more important for weight loss than the exact number of steps. Your body weight, effort, and pace affect how many calories you burn from walking. Adding intensity ...
Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...
Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.
GLP-1 medications can be effective for weight loss and diabetes management but require lifestyle changes and can have severe ...
It’s estimated that about one in 10 Americans have taken a GLP‑1 weight‑loss drug, and demand is surging. Ads are everywhere, but so are concerns about safety, cost and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results